Related references
Note: Only part of the references are listed.Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study
Yukiko Hasuike et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2010)
Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial
Joanne H. Lau et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Key Comorbid Conditions that Are Predictive of Survival among Hemodialysis Patients
Dana Miskulin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The Normal Hematocrit Cardiac Trial Revisited
David A. Goodkin
SEMINARS IN DIALYSIS (2009)
The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data
Victor E. Pollak et al.
BMC NEPHROLOGY (2009)
Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets
Steven Fishbane et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
Deborah L. Regidor et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Challenging the validity of the EPO index
GA Kaysen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS)
DA Goodkin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients
VE Pollak et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2001)
Serum ferritin is a marker of morbidity and mortality in hemodialysis patients
K Kalantar-Zadeh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Share Paper
